Market closedNon-fractional

Lexicon Pharmaceuticals/LXRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Ticker

LXRX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

The Woodlands, United States

Employees

285

LXRX Metrics

BasicAdvanced
$600M
Market cap
-
P/E ratio
-$0.82
EPS
1.38
Beta
-
Dividend rate
$600M
1.38
15.584
15.262
36.333
36.78
-11.46%
-40.08%
-102.72%
169.043
1.42
1.68
-2.103
1,733.33%
30.97%
-47.56%
96.14%

What the Analysts think about LXRX

Analyst Ratings

Majority rating from 5 analysts.
Buy

LXRX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-4,390.90% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.1M
57.14%
Net income
-$48M
-2.82%
Profit margin
-4,390.90%
-38.16%

LXRX Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 1.27%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.22
-$0.21
-$0.20
-$0.20
-
Expected
-$0.17
-$0.21
-$0.22
-$0.20
-$0.19
Surprise
25.89%
-2.21%
-7.94%
1.27%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Lexicon Pharmaceuticals stock?

Lexicon Pharmaceuticals (LXRX) has a market cap of $600M as of July 05, 2024.

What is the P/E ratio for Lexicon Pharmaceuticals stock?

The price to earnings (P/E) ratio for Lexicon Pharmaceuticals (LXRX) stock is 0 as of July 05, 2024.

Does Lexicon Pharmaceuticals stock pay dividends?

No, Lexicon Pharmaceuticals (LXRX) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Lexicon Pharmaceuticals dividend payment date?

Lexicon Pharmaceuticals (LXRX) stock does not pay dividends to its shareholders.

What is the beta indicator for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals (LXRX) has a beta rating of 1.38. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Lexicon Pharmaceuticals stock

Buy or sell Lexicon Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing